Jeremy Tan, MD
Ophthalmic Plastic and Reconstructive Surgery · Oklahoma City, OKNPI 1124387626
Payments from drug & device makers
Across 146 payments — averaging $340.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$33K
- Kerecis Limited$15K
- Axogen$257
- AbbVie$226
- Merz Pharmaceuticals, LLC$197
- Biotissue Holdings Inc.$186
- plus $720 from 12 others
Across 1 payment — averaging $16,050 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Kerecis Limited$16K
What the payments were for
- Consulting fees$1,4883%
- Speaking & faculty fees$36,31873%
- Travel & lodging$4,2439%
- Food & beverage$5,05110%
- Education$2,5835%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 91 | $33,157 |
| Kerecis Limited | 13 | $14,940 |
| Axogen | 5 | $257 |
| AbbVie(2 entities) | 6 | $226 |
| Merz Pharmaceuticals, LLC | 10 | $197 |
| Biotissue Holdings Inc. | 1 | $186 |
| Alcon | 5 | $173 |
| Vertex | 1 | $120 |
| Acera Surgical, Inc. | 2 | $110 |
| Bioventus LLC | 1 | $100 |
| Johnson & Johnson | 2 | $68 |
| Merz North America, Inc. | 3 | $45 |
| Polynovo North America LLC | 1 | $24 |
| Bausch & Lomb Americas Inc. | 1 | $20 |
| Organogenesis Inc. | 1 | $19 |
| Novartis | 1 | $14 |
| Baxter Healthcare | 1 | $13 |
| Galderma Laboratories, L.p. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$48,403
- TEPEZZA$30,589
- Kerecis Omega3 SurgiClose$12,141
- Kerecis SurgiClose$10,947
- Kerecis GraftGuide$2,737
- Prokera$186
- AmnioGraft$186
- Kerecis Omega3 GraftGuide$160
- BOTOX COSMETIC$122
- NEXUS-10 MKII$100
How this compares
Too few ophthalmic plastic and reconstructive surgery providers in Oklahomato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErythromycinErythromycin Base | 428 | $4,562 |
| ValacyclovirValacyclovir Hcl | 18 | $383 |
| Doxycycline Monohydrate | 29 | $344 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 25 | $327 |
| Ketorolac Tromethamine | 17 | $294 |
| Cephalexin | 55 | $267 |
| Fluticasone Propionate | 17 | $226 |
| Bacitracin-PolymyxinBacitracin/Polymyxin B Sulfate | 11 | $168 |
| Methylprednisolone | 16 | $110 |
Paid to pharmacies, not to this prescriber.
Other ophthalmic plastic and reconstructive surgery in Oklahoma City
- Annie MoreauOklahoma City$7K
- Thai DoOklahoma City$4K
- Diana TamboliOklahoma City$54
- Shannon CoxTulsa$3K
- Neel KumarTulsa$1K
- Christian PonderEdmond$291
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.